Trial of sirukumab for lupus nephritis falls flat

PARIS – The investigational interleukin-6 blocker sirukumab provided no benefit to patients with lupus nephritis but put them at a very high risk of developing a serious infection in a small,...

Field of Interest: Rheumatology
Type: News Item

No blood clot risk found with HPV vaccination

The quadrivalent human papillomavirus vaccine does not increase the risk of venous thromboembolism, a study showed. Two previous studies finding an association, one based on the Vaccine Adverse...

Field of Interest: Pulmonology
Type: News Item

Desonide hydrogel improved itching in atopic dermatitis

Twice-daily application of 0.05% desonide hydrogel significantly improved clinical symptoms of itching and quality of life scores in 100% of patients with mild to moderate atopic dermatitis after 7...

Field of Interest: Dermatology
Type: News Item

Real-world use supports belimumab clinical trial data

PARIS – Belimumab produced significant clinical improvement in 74% of patients with systemic lupus erythematosus who took it over a 6-month period, reducing disease symptoms and steroid use and...

Field of Interest: Rheumatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness